Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5884)	10/9/1998 4:56:00 PM
From: Rob Loney	Read Replies (1) \| Respond to of 9523

I'm not sure when PFE reports, however, I feel the results will be very uplifting. So much attention has been pain to viagra, that many of the other success stories have been overlooked. The co-marketing success with Parke-Davis's Lipitor, for one, will really open some eyes. Look out MERCK & BMS shareholders, this business is coming from somewhere!

To: Anthony Wong who wrote (5884)	10/9/1998 6:09:00 PM
From: John F. Dowd	Read Replies (2) \| Respond to of 9523

Anthony and Rob: I can't see how earnings can disappoint. Hang on elevator going up! John P.S. This note might be of interest if you don't see it on the INTC board AFTER THE BELL - Intel rises after new estimates Friday, October 9, 1998 05:35 PM Mail this article to a friend NEW YORK, Oct 9 (Reuters) - Shares of Intel Corp. (Nasdaq:INTC) continued to edge up in post-session trading after brokerage house Piper Jaffray raised its third and four quarter earnings estimates for the microcomputer component maker earlier in the day. The company's stock was trading up 2/16 at 83-15/16 after hours after an analyst raised Intel's third quarter earnings per share estimate to $0.84 from $0.80. The increase came after a 5-3/8 rise in the stock during the regular session.